Cargando…

Patient-Derived Xenograft Models to Improve Targeted Therapy in Epithelial Ovarian Cancer Treatment

Despite increasing evidence that precision therapy targeted to the molecular drivers of a cancer has the potential to improve clinical outcomes, high-grade epithelial ovarian cancer (OC) patients are currently treated without consideration of molecular phenotype, and predictive biomarkers that could...

Descripción completa

Detalles Bibliográficos
Autores principales:	Scott, Clare L., Becker, Marc A., Haluska, Paul, Samimi, Goli
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2013
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3849703/ https://www.ncbi.nlm.nih.gov/pubmed/24363999 http://dx.doi.org/10.3389/fonc.2013.00295

Ejemplares similares

Patient-Derived Xenografts Are a Reliable Preclinical Model for the Personalized Treatment of Epithelial Ovarian Cancer
por: Chen, Jiayu, et al.
Publicado: (2021)

Prevention of Human Lymphoproliferative Tumor Formation in Ovarian Cancer Patient-Derived Xenografts()()
por: Butler, Kristina A., et al.
Publicado: (2017)

Tumor Tissue Explant Culture of Patient-Derived Xenograft as Potential Prioritization Tool for Targeted Therapy
por: Ghosh, Susmita, et al.
Publicado: (2019)

Pediatric Anaplastic Embryonal Rhabdomyosarcoma: Targeted Therapy Guided by Genetic Analysis and a Patient-Derived Xenograft Study
por: Cramer, Stuart L., et al.
Publicado: (2018)

Conventional Chemotherapy and Oncogenic Pathway Targeting in Ovarian Carcinosarcoma Using a Patient-Derived Tumorgraft
por: Glaser, Gretchen, et al.
Publicado: (2015)

Understanding the Key to Targeting the IGF Axis in Cancer: A Biomarker Assessment
por: Lodhia, Kunal Amratlal, et al.
Publicado: (2015)

Statistical analysis of comparative tumor growth repeated measures experiments in the ovarian cancer patient derived xenograft (PDX) setting
por: Oberg, Ann L., et al.
Publicado: (2021)

Utility of Glioblastoma Patient-Derived Orthotopic Xenografts in Drug Discovery and Personalized Therapy
por: Patrizii, Michele, et al.
Publicado: (2018)

Gene expression differences between matched pairs of ovarian cancer patient tumors and patient-derived xenografts
por: Liu, Yuanhang, et al.
Publicado: (2019)

Patient-Derived Xenograft Models of Epithelial Ovarian Cancer for Preclinical Studies
por: Heo, Eun Jin, et al.
Publicado: (2017)

Etiology and Pathogenesis of Epithelial Ovarian Cancer
por: Mok, Samuel C., et al.
Publicado: (2007)

Ovarian Real-World International Consortium (ORWIC): A multicentre, real-world analysis of epithelial ovarian cancer treatment and outcomes
por: Cheeseman, Sue, et al.
Publicado: (2023)

A Translational Model to Improve Early Detection of Epithelial Ovarian Cancers
por: Gockley, Allison, et al.
Publicado: (2022)

In situ Metabolic Profiling of Ovarian Cancer Tumor Xenografts: A Digital Pathology Approach
por: Piga, Ilaria, et al.
Publicado: (2020)

Immunomodulatory Effects of Perioperative Dexmedetomidine in Ovarian Cancer: An In Vitro and Xenograft Mouse Model Study
por: Shin, Seokyung, et al.
Publicado: (2021)

Establishing and Maintaining an Extensive Library of Patient-Derived Xenograft Models
por: Mattar, Marissa, et al.
Publicado: (2018)

CHTOP in Chemoresistant Epithelial Ovarian Cancer: A Novel and Potential Therapeutic Target
por: Feng, Xiaojie, et al.
Publicado: (2019)

Clinically relevant glioblastoma patient-derived xenograft models to guide drug development and identify molecular signatures
por: Alcaniz, Joshua, et al.
Publicado: (2023)

A Molecularly Characterized Preclinical Platform of Subcutaneous Renal Cell Carcinoma (RCC) Patient-Derived Xenograft Models to Evaluate Novel Treatment Strategies
por: Gürgen, Dennis, et al.
Publicado: (2022)

Longitudinal characterization of primary osteosarcoma and derived subcutaneous and orthotopic relapsed patient-derived xenograft models
por: da Costa, Maria Eugenia Marques, et al.
Publicado: (2023)

Integrated molecular and pharmacological characterization of patient-derived xenografts from bladder and ureteral cancers identifies new potential therapies
por: Lang, Hervé, et al.
Publicado: (2022)

Role of EZH2 in Epithelial Ovarian Cancer: From Biological Insights to Therapeutic Target
por: Li, Hua, et al.
Publicado: (2013)

Screening of an individualized treatment strategy for an advanced gallbladder cancer using patient-derived tumor xenograft and organoid models
por: Tan, Dengxu, et al.
Publicado: (2022)

Ovarian tumour xenografts in the study of the biology of human epithelial ovarian cancer.
por: Friedlander, M. L., et al.
Publicado: (1985)

In vivo loss of tumorigenicity in a patient-derived orthotopic xenograft mouse model of ependymoma
por: Whitehouse, Jacqueline P., et al.
Publicado: (2023)

Epithelial–Mesenchymal Transition in Ovarian Carcinoma
por: Davidson, Ben, et al.
Publicado: (2012)

c-MYC and Epithelial Ovarian Cancer
por: Reyes-González, Jeyshka M., et al.
Publicado: (2021)

Editorial: Advances in Epithelial Ovarian Cancer: Model Systems, Microenvironmental Influences, Therapy, and Origins
por: Howell, Viive Maarika, et al.
Publicado: (2015)

Development of Novel Patient-Derived Xenografts from Breast Cancer Brain Metastases
por: Contreras-Zárate, María J., et al.
Publicado: (2017)

The Application Progress of Patient-Derived Tumor Xenograft Models After Cholangiocarcinoma Surgeries
por: Wu, Jun, et al.
Publicado: (2021)

Patient-Derived Xenograft Models for Intrahepatic Cholangiocarcinoma and Their Application in Guiding Personalized Medicine
por: Gao, Yang, et al.
Publicado: (2021)

Ovarian Tumor Attachment, Invasion, and Vascularization Reflect Unique Microenvironments in the Peritoneum: Insights from Xenograft and Mathematical Models
por: Steinkamp, Mara P., et al.
Publicado: (2013)

Patient-derived xenograft models for gastrointestinal tumors: A single-center retrospective study
por: Yu, Xiongfei, et al.
Publicado: (2022)

Patient-derived xenografts or organoids in the discovery of traditional and self-assembled drug for tumor immunotherapy
por: Zhang, Wei, et al.
Publicado: (2023)

Autologous humanized mouse models to study combination and single-agent immunotherapy for colorectal cancer patient-derived xenografts
por: Kanikarla Marie, Preeti, et al.
Publicado: (2022)

Evaluating Imaging Biomarkers of Acquired Resistance to Targeted EGFR Therapy in Xenograft Models of Human Head and Neck Squamous Cell Carcinoma
por: Baker, Lauren C. J., et al.
Publicado: (2018)

Targeting oxidative phosphorylation as an approach for the treatment of ovarian cancer
por: Wu, Yinjie, et al.
Publicado: (2022)

Humanized Ovarian Cancer Patient-Derived Xenografts for Improved Preclinical Evaluation of Immunotherapies
por: Kleinmanns, Katrin, et al.
Publicado: (2022)

Genomic and Molecular Signatures of Successful Patient-Derived Xenografts for Oral Cavity Squamous Cell Carcinoma
por: Yen, Wei-Chen, et al.
Publicado: (2022)

Novel myeloma patient-derived xenograft models unveil the potency of anlotinib to overcome bortezomib resistance
por: Yue, Yanhua, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ild08hitqqpb6bnvj4add5qsrh